Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 450 of 1863 entries
View as:

Theranostics of Radiolabeled Somatostatin Antagonists 68Ga-DOTA-JR11 and 177Lu-DOTA-JR11 in Patients With Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02609737 Org: User:
Start: 11/13/15 End: 12/10/20 Due: 12/10/21

10-Propargyl-10-Deazaaminopterin Plus Probenecid in Treating Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00024245 Org: User:
Start: 05/31/01 End: 04/30/03 Due: 04/30/04

Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00911118 Org: User:
Start: 05/31/09 End: 05/31/26 Due: 05/31/27

A Study of Attention and Memory Processes in Breast Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT04883398 Org: User:
Start: 05/06/21 End: 05/31/26 Due: 05/31/27

Development of Psychotherapeutic Interventions for Parents Who Lost a Child

Phase: N/A Priority: Normal
NCT ID: NCT02153619 Org: User:
Start: 05/31/14 End: 05/31/26 Due: 05/31/27

Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01916109 Org: User:
Start: 08/31/13 End: - Due: -

Study of Radiation Exposure and Bilateral Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00903591 Org: User:
Start: 05/31/09 End: 05/31/26 Due: 05/31/27

Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for the Chinese Community

Phase: N/A Priority: Normal
NCT ID: NCT02914899 Org: User:
Start: 08/31/16 End: 05/31/26 Due: 05/31/27

A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma

Phase: N/A Priority: Normal
NCT ID: NCT06843967 Org: User:
Start: 02/19/25 End: 08/19/28 Due: 08/19/29

Paclitaxel Plus Monoclonal Antibody Therapy in Treating Women With Recurrent or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003539 Org: User:
Start: 04/30/98 End: 02/28/03 Due: 02/28/04

Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00039195 Org: User:
Start: 11/30/06 End: 01/31/10 Due: 01/31/11

Erlotinib Re-Challenge for Recurrent EGFR-mutant Lung Cancer in Patients Who Previously Received Adjuvant Erlotinib or Gefitinib

Phase: N/A Priority: Normal
NCT ID: NCT01189435 Org: User:
Start: 08/31/10 End: 01/31/12 Due: 01/31/13

First Line Gemcitabine, Cisplatin and MEK162 in Advanced Biliary Tract Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01828034 Org: User:
Start: 04/30/13 End: 05/30/19 Due: 05/30/20

Expressive Writing and Adjustment to Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00624156 Org: User:
Start: 02/29/08 End: 01/31/12 Due: 01/31/13

Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01466946 Org: User:
Start: 11/30/11 End: 02/29/16 Due: 02/28/17

Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated Donor

Phase: N/A Priority: Normal
NCT ID: NCT00582933 Org: User:
Start: 05/31/01 End: 04/30/09 Due: 04/30/10

Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01294670 Org: User:
Start: 02/09/11 End: 12/08/20 Due: 12/08/21

Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003345 Org: User:
Start: 10/31/97 End: 10/31/01 Due: 10/31/02

Treatment of Elderly AML Patients With Induction Chemotherapy Followed by G-CSF-Mobilized Stem Cells From Haploidentical Related Donors

Phase: N/A Priority: Normal
NCT ID: NCT02519712 Org: User:
Start: 07/28/15 End: 09/30/17 Due: 09/30/18

AIDS and Cancer Specimen Bank (ACSB)

Phase: N/A Priority: Normal
NCT ID: NCT00587912 Org: User:
Start: 06/30/97 End: 04/30/11 Due: 04/30/12

Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk

Phase: N/A Priority: Normal
NCT ID: NCT00735150 Org: User:
Start: 03/31/08 End: 10/31/10 Due: 10/31/11

A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients

Phase: N/A Priority: Normal
NCT ID: NCT03352765 Org: User:
Start: 11/20/17 End: 11/30/25 Due: 11/30/26

Emotion Regulation Therapy to Address Distress Among Caregivers

Phase: N/A Priority: Normal
NCT ID: NCT02697357 Org: User:
Start: 10/31/15 End: 07/09/20 Due: 07/09/21

PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00002930 Org: User:
Start: 12/31/96 End: - Due: -

Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases

Phase: N/A Priority: Normal
NCT ID: NCT01470105 Org: User:
Start: 11/30/11 End: 11/30/25 Due: 11/30/26